Hepatic fibrosis. Pathogenesis and principles of therapy (Q34269628)

1 August 2017

1 reference

title

Hepatic fibrosis. Pathogenesis and principles of therapy (English)

1 reference

1 August 2017

0 references

Albanis E

1

1 reference

PubMed ID

11385966

1 August 2017

Friedman SL

series ordinal

2

1 reference

1 August 2017

1 May 2001

1 reference

1 August 2017

Clinics in liver disease

1 reference

1 August 2017

5

1 reference

1 August 2017

315-34, v-vi

1 reference

1 August 2017

2

1 reference

Preventive effect of malotilate on carbon tetrachloride-induced liver damage and collagen accumulation in the rat.

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Evaluation of colchicine therapy in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumour necrosis factor as therapeutic modalities for concanavalin A induced hepatitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Trends in cirrhosis morbidity and mortality: United States, 1979-1988.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Effects of long-term administration of interferon α in two models of liver fibrosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Cytokines and fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Sho-saiko-To: the right blend of traditional Oriental medicine and liver cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

The lipocytes in normal human liver. A quantitative study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Molecular mechanisms of liver fibrogenesis--a homage to the role of activated fat-storing cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Nitric oxide and hemodynamic impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Distributions of retinoids, retinoid-binding proteins and related parameters in different types of liver cells isolated from young and old rats

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

A prospective trial of colchicine for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

The prognosis of patients with alcoholic liver disease. An international randomized, placebo-controlled trial on the effect of malotilate on survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Experimental and human liver fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Effects of sho-saiko-to extract on fibrosis and regeneration of the liver in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Alpha-interferon prevents liver collagen deposition and damage induced by prolonged bile duct obstruction in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Metals, oxidative stress, and hepatic fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Antioxidant activity of silybin in vivo during long-term iron overload in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Expression of platelet-derived growth factor in a model of acute liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Antisense oligodeoxyribonucleotide inhibition of TGF-beta 1 gene expression and alterations in the growth and malignant properties of mouse fibrosarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin-10 during the course of activation In vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Macromolecular organization of basement membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Characterization of recombinant soluble human transforming growth factor-beta receptor type II (rhTGF-beta sRII).

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Hepatic stellate cells and intralobular innervation in human liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

The results of a randomized double blind controlled trial evaluating malotilate in primary biliary cirrhosis. A European multicentre study group

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Chronic alcohol intake interferes with retinoid metabolism and signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Salvia miltiorrhiza reduces experimentally-induced hepatic fibrosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

Detection of hepatic fibrogenesis: a review of available techniques

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970168-9

7 January 2021

10.1016/S1089-3261(05)70168-9

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11385966